RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,540,807 | +12.1% | 92,708 | +26.1% | 0.00% | – |
| Q2 2023 | $1,374,543 | -46.2% | 73,505 | -47.2% | 0.00% | – |
| Q1 2023 | $2,554,981 | -9.9% | 139,236 | -2.8% | 0.00% | – |
| Q4 2022 | $2,835,103 | +138.8% | 143,187 | +190.2% | 0.00% | – |
| Q3 2022 | $1,187,000 | +623.8% | 49,338 | +449.1% | 0.00% | – |
| Q2 2022 | $164,000 | -79.3% | 8,986 | -75.1% | 0.00% | – |
| Q1 2022 | $794,000 | -73.7% | 36,123 | -56.1% | 0.00% | – |
| Q4 2021 | $3,020,000 | +967.1% | 82,233 | +800.6% | 0.00% | – |
| Q3 2021 | $283,000 | +13.2% | 9,131 | +15.7% | 0.00% | – |
| Q2 2021 | $250,000 | +45.3% | 7,895 | +1.7% | 0.00% | – |
| Q1 2021 | $172,000 | +95.5% | 7,760 | +73.5% | 0.00% | – |
| Q4 2020 | $88,000 | -26.7% | 4,473 | +20.3% | 0.00% | – |
| Q3 2020 | $120,000 | -81.9% | 3,717 | -83.7% | 0.00% | – |
| Q2 2020 | $663,000 | +5425.0% | 22,870 | +3870.5% | 0.00% | – |
| Q1 2020 | $12,000 | +71.4% | 576 | +142.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |